Attovia Therapeutics, Inc. (ATTO) Earnings Call Transcripts

13 earnings calls from March 2020 to September 16, 2026

NasdaqGM US Health Care Biotechnology

About Attovia Therapeutics, Inc.

Attovia Therapeutics, Inc. (ATTO) is a publicly listed company in the Biotechnology industry, within the Health Care sector. It trades on NasdaqGM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 13 calls on record spanning March 4, 2020 to September 16, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 13 Attovia Therapeutics, Inc. earnings call transcripts on record, spanning March 4, 2020 to September 16, 2026. Based on this history, Attovia Therapeutics, Inc. reports semi-annually. The most recent call on file is dated September 16, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ATTO
Exchange
NasdaqGM
Country
US
Sector
Health Care
Industry
Biotechnology
Calls on record
13
First call
March 4, 2020
Most recent
September 16, 2026
Reporting cadence
semi-annually
Quarter Date
Company Conference Presentations Sep 16, 2026 Read transcript →
Q3 FY2022 Nov 16, 2022 Read transcript →
Q2 FY2022 Aug 4, 2022 Read transcript →
Q1 FY2022 May 12, 2022 Read transcript →
Q4 FY2021 Mar 31, 2022 Read transcript →
Q3 FY2021 Nov 16, 2021 Read transcript →
Q2 FY2021 Aug 5, 2021 Read transcript →
Q1 FY2021 May 6, 2021 Read transcript →
Q4 FY2020 Mar 4, 2021 Read transcript →
Q3 FY2020 Nov 12, 2020 Read transcript →
Q2 FY2020 Aug 6, 2020 Read transcript →
Q1 FY2020 May 8, 2020 Read transcript →
Q4 FY2019 Mar 4, 2020 Read transcript →